Find Paid Clinical Trials in Texas

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Texas

Top of Directory » All Locations » United States » Texas




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients

    Condition:   Moderate to Severe Postoperative Pain
    Interventions:   Drug: Q8003;   Drug: Morphine sulfate;   Drug: Oxycodone HCl
    Sponsor:   QRxPharma Inc.
    Not yet recruiting - verified November 2009

  • A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: RO5095932;   Drug: Placebo;   Drug: RO5095932;   Drug: Placebo
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Treximet Early Intervention Adolescent Migraine

    Condition:   Adolescent Migraine
    Intervention:   Drug: Treximet
    Sponsors:   Premiere Research Institute;   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Clinical Evaluation of a Silicone Hydrogel Lens

    Condition:   Lotrafilcon A Contact Lens Use
    Intervention:  
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies

    Condition:   Advanced Cancer
    Interventions:   Drug: Dasatinib;   Drug: Bevacizumab;   Drug: Paclitaxel
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting - verified November 2009

  • Study of NMS-1116354 in Solid Tumors

    Condition:   Advanced Solid Tumors
    Intervention:   Drug: NMS-1116354
    Sponsor:   Nerviano Medical Sciences
    Recruiting - verified November 2009

  • Chemotherapy-Induced Peripheral Neuropathy Survey

    Conditions:   Breast Cancer;   Colorectal Cancer;   Myeloma;   Chemotherapy-Induced Peripheral Neuropathy
    Interventions:   Behavioral: Questionnaire;   Behavioral: Sensory Tests;   Behavioral: Interview
    Sponsor:   M.D. Anderson Cancer Center
    Not yet recruiting - verified November 2009

  • Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients

    Condition:   Cachexia
    Intervention:  
    Sponsor:   The University of Texas, Galveston
    Recruiting - verified November 2009

  • A Trial to Evaluate the Safety and Immunogenicity of a Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) in Older Adults

    Condition:   Influenza
    Interventions:   Biological: Investigational Influenza VLP Vaccine 15ug/strain;   Biological: Investigational Influenza VLP Vaccine 60ug/strain;   Biological: TIV
    Sponsor:   Novavax
    Recruiting - verified November 2009

  • Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)

    Conditions:   Venous Thromboembolism;   Traumatic Brain Injury
    Interventions:   Drug: enoxaparin;   Drug: placebo
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting - verified November 2009

  • Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

    Conditions:   Mild Traumatic Brain Injury;   Post-Traumatic Stress Disorder
    Interventions:   Drug: Atorvastatin;   Drug: Placebo
    Sponsors:   Baylor College of Medicine;   The University of Texas Health Science Center, Houston
    Not yet recruiting - verified November 2009

  • First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor EMD 1214063 in Subjects With Advanced Solid Tumors

    Condition:   Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
    Interventions:   Drug: EMD 1214063;   Drug: EMD 1214063
    Sponsor:   EMD Serono
    Recruiting - verified November 2009

  • Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

    Conditions:   Brain Cancer;   Choroid Plexus Tumors
    Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Dactinomycin;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Irinotecan;   Drug: Leucovorin;   Drug: Methotrexate;   Drug: Temozolomide;   Drug: Vincristine
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting - verified November 2009

  • The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart

    Condition:   Ventricular Function
    Interventions:   Behavioral: Aerobic Exercise Training;   Drug: Alagebrium (generic: ALT-711);   Behavioral: Tai Chi and/or Yoga Training
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting - verified November 2009

  • A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease

    Condition:   Dry Eye Disease
    Interventions:   Drug: Azithromycin Ophthalmic Solution, 1%;   Drug: Placebo
    Sponsor:   Inspire Pharmaceuticals
    Recruiting - verified November 2009

  • AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study

    Condition:   Coronary Occlusions
    Intervention:   Device: everolimus-eluting stent
    Sponsor:   North Texas Veterans Healthcare System
    Recruiting - verified November 2009

  • Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

    Condition:   Adult ADHD
    Interventions:   Drug: AZD1446;   Drug: AZD1446;   Drug: AZD1446;   Drug: Placebo
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

    Condition:   Lung Cancer, Stage IIIb or IV
    Intervention:   Other: CHESS website for lung cancer patient + internet access if needed
    Sponsors:   University of Wisconsin, Madison;   Harry Gray Cancer Center Hartford Hospial;   M.D. Anderson Cancer Center;   University of Illinois;   University of Wisconsin Carbone Cancer Center
    Not yet recruiting - verified November 2009

  • Physician Perceptions About Parenteral Hydration in Latin America and Spain

    Conditions:   Dehydration;   Advanced Cancers
    Intervention:   Behavioral: Survey
    Sponsor:   M.D. Anderson Cancer Center
    Not yet recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Lisdexamfetamine Dimesylate Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

    Condition:   Attention-Deficit Hyperactivity Disorder
    Interventions:   Drug: Lisdexamfetamine Dimesylate;   Drug: Immediate Release Mixed Amphetamine Salts;   Drug: LDX Placebo + MAS-IR Placebo
    Sponsor:   Shire Pharmaceutical Development
    Not yet recruiting - verified November 2009

  • Methods to Augment the Efficacy of Aspirin and Clopidogrel in Healthy Subjects and Patients With Stable Coronary Artery Disease With an Elevated Platelet Turnover (Reticulated Platelets)

    Condition:   Coronary Artery Disease
    Interventions:   Drug: Asprin;   Drug: Clopidogrel
    Sponsor:   The Methodist Hospital System
    Recruiting - verified November 2009

  • Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System

    Conditions:   Back Pain;   Chronic Low Back Pain;   Internal Disc Disruption;   Degenerative Disc Disease
    Interventions:   Biological: Biostat System;   Drug: Sodium Chloride Injection
    Sponsor:   Spinal Restoration, Inc.
    Not yet recruiting - verified November 2009

  • Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

    Condition:   Staphylococcus Aureus
    Interventions:   Biological: Monovalent rAT;   Biological: Monovalent rLukS-PV;   Biological: Bivalent rLukS-PV / rAT;   Biological: Placebo with adjuvant;   Biological: Placebo
    Sponsors:   Uniformed Services University of the Health Sciences;   Nabi Biopharmaceuticals
    Recruiting - verified November 2009

  • Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

    Conditions:   Stem Cell Transplantation;   Leukemia;   Hematologic Malignancies
    Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Mesna;   Drug: Rituximab;   Procedure: Stem Cell Transplantation;   Drug: Thiotepa
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting - verified November 2009

  • A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

    Condition:   Melanoma
    Interventions:   Drug: YM155;   Drug: Docetaxel
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System

    Conditions:   Solid Tumors;   Cancer
    Interventions:   Procedure: PET/CT Scan;   Procedure: HR PEM Scan
    Sponsor:   M.D. Anderson Cancer Center
    Not yet recruiting - verified November 2009

  • CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia

    Condition:   Chronic Lymphocytic Leukemia
    Intervention:   Biological: Infusion of CD3/CD28 stimulated T cells
    Sponsors:   University of Pennsylvania;   M.D. Anderson Cancer Center
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • A Pharmacokinetic/Pharmacodynamic Study of Intravenous and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis on Methotrexate

    Conditions:   Arthritis;   Rheumatoid Arthritis
    Interventions:   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Other: Placebo IV;   Other: Placebo SC
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • Motivational Interviewing for Physical Activity

    Condition:   Cancer
    Interventions:   Behavioral: Training;   Behavioral: Questionnaire;   Behavioral: Interview;   Behavioral: PA Newsletter
    Sponsors:   M.D. Anderson Cancer Center;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

    Condition:   Hydatidiform Moles
    Intervention:  
    Sponsor:   Baylor College of Medicine
    Recruiting - verified November 2009

  • Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

    Condition:   Lymphoma, Large-Cell, Diffuse
    Interventions:   Drug: RITUXIMAB + DHAP;   Drug: RITUXIMAB + DVD;   Drug: OFATUMUMAB + DVD;   Drug: OFATUMUMAB + DHAP
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

    Condition:   COPD
    Intervention:   Drug: R7103
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery

    Condition:   Ischemic Stroke
    Interventions:   Device: tDCS;   Device: Sham tDCS
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting - verified November 2009

  • The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique

    Condition:   Pediatric Hydrocephalus
    Intervention:  
    Sponsor:   University of Utah
    Recruiting - verified November 2009

  • Markers of Response to Intravesical Bladder Cancer Therapy

    Condition:   Bladder Cancer
    Intervention:  
    Sponsors:   M.D. Anderson Cancer Center;   Flight Attendant Medical Research Institute
    Recruiting - verified November 2009

  • Intensive Lipid-Lowering Therapy for Patients With Acute Coronary Syndrome

    Condition:   Acute Coronary Syndrome
    Interventions:   Procedure: Percutaneous coronary intervention;   Procedure: Intravascular ultrasound with virtual histology;   Drug: Atorvastatin;   Device: LDL-apheresis
    Sponsor:   Department of Veterans Affairs
    Not yet recruiting - verified October 2009

  • A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

    Conditions:   Excessive Daytime Sleepiness;   Narcolepsy
    Interventions:   Drug: Placebo;   Drug: PF-03654746
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients

    Conditions:   Advanced Cancers;   Melanoma
    Intervention:   Procedure: Tumor Interstitial Fluid Pressure (IFP) assessments
    Sponsor:   M.D. Anderson Cancer Center
    Not yet recruiting - verified November 2009

  • Conjoint Analysis of Treatment Preferences for Osteoarthritis

    Condition:   Osteoarthritis
    Interventions:   Behavioral: Standard of care for osteoarthritis treatment;   Behavioral: Conjoint Analysis for Osteoarthritis
    Sponsors:   Baylor College of Medicine;   Agency for Healthcare Research and Quality (AHRQ);   M.D. Anderson Cancer Center
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials